Understanding the Continuum of Care in SMA: The Importance of Early Diagnosis, Optimal Treatment, and Transitioning from Pediatric to Adult Care Teams

Target Audience
This activity is intended for OB/GYNs and neurologists, as well as physician assistants, nurse practitioners, and nurses involved in the diagnosis and management of SMA. This activity will provide education to a multidisciplinary team whom will be invited to participate.

Program Overview
This enduring continuing medical education (CME) activity is an archive of the live broadcast from November 17, 2020, featuring 4 spinal muscular atrophy (SMA) specialists who address the latest in evidence-based management strategies for this neurologic disorder. They provide their clinical data perspectives supporting the importance of early diagnosis, current and emerging treatments, and transitioning care from pediatric to adult medical specialties. Prenatal and newborn screening, implementing early treatments, safety and availability of new and emerging treatments, and overcoming barriers when transitioning care as patients with SMA age is also addressed by the panel.

Learning Objectives
Upon completion of this activity, participants will be able to:

Evaluate novel and emerging approaches to prenatal and newborn screening for SMA
Describe clinical trial evidence that demonstrates the benefits of early treatment implementation in patients with SMA
Analyze appropriate treatments for pediatric and adult patients with SMA based on currently available efficacy and safety data of current and emerging therapies
Integrate team-based strategies to improve transition of care in patients with SMA as age increases